Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys

被引:25
|
作者
Marti-Pastor, Marc [1 ,2 ,3 ]
Pont, Angels [1 ,2 ]
Avila, Monica [1 ,2 ,4 ]
Garin, Olatz [1 ,2 ,4 ]
Vilagut, Gemma [1 ,2 ,4 ]
Forero, Carlos G. [1 ,2 ,4 ]
Pardo, Yolanda [1 ,2 ,3 ]
Tresserras, Ricard [4 ,5 ]
Medina-Bustos, Antonia [5 ]
Garcia-Codina, Oriol [5 ]
Cabases, Juan [6 ]
Rajmil, Luis [1 ,2 ,7 ]
Alonso, Jordi [1 ,2 ,4 ]
Ferrer, Montse [1 ,2 ,3 ]
机构
[1] IMIM Hosp Mar Med Res Inst, Hlth Serv Res Grp, Doctor Aiguader 88, Barcelona 08003, Spain
[2] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
[3] Univ Autonoma Barcelona, Barcelona, Spain
[4] Univ Pompeu Fabra, Barcelona, Spain
[5] Dept Salut Gen Catalunya, Direccio Gen Planificacio Salut, Barcelona, Spain
[6] Univ Publ Navarra, Pamplona, Spain
[7] Agcy Healthcare Qual & Assessment Catalonia AQuAS, Barcelona, Spain
来源
POPULATION HEALTH METRICS | 2018年 / 16卷
关键词
Quality of life; Health survey; Validity and reliability; Perceived health; QUALITY-OF-LIFE; CANCER-PATIENTS; OUTCOME MEASURES; 5-LEVEL VERSION; UNITED-KINGDOM; STANDARD EQ-5D; PATIENT GROUPS; RESPONSIVENESS; INSTRUMENTS; VALIDITY;
D O I
10.1186/s12963-018-0170-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The EQ-5D has been frequently used in national health surveys. This study is a head-to-head comparison to assess how expanding the number of levels from three (EQ-5D-3L) to five in the new EQ-5D-5L version has improved its distribution, discriminatory power, and validity in the general population. Methods: A representative sample (N = 7554) from the Catalan Health Interview Survey 2011-2012, aged >= 18, answered both EQ-5D versions, and we evaluated the response redistribution and inconsistencies between them. To assess validity of this redistribution, we calculated the mean of the Visual Analogue Scale (VAS), which measures perceived health. The discriminatory power was examined with Shannon Indices, calculated for each dimension separately. Spanish preference value sets were applied to obtain utility indices, examining their distribution with statistics of central tendency and dispersion. We estimated the proportion of individuals reporting the best health state in EQ-5D-5L and EQ-5D-3L within groups of specific chronic conditions and their VAS mean. Results: A very small reduction in the percentage of individuals with the best health state was observed, from 61.8% in EQ-5D-3L to 60.8% in EQ-5D-5L. In contrast, a large proportion of individuals reporting extreme problems in the 3 L version moved to severe problems (level 4) in the 5 L version, particularly for pain/discomfort (75.5%) and anxiety/depression (66.4%). The average proportion of inconsistencies was 0.9%. The pattern of the perceived health VAS mean confirmed the hypothesis established a priori, supporting the validity of the observed redistribution. Shannon index showed that absolute informativity was higher in the 5 L version for all dimensions. The means (SD) of the Spanish EQ5D- 3L and EQ-5D-5L indices were 0.87 (0.25) and 0.89 (0.22). The proportion of individuals with the best health state within each specific chronic condition was very similar, regardless of the EQ-5D version (<= 30% in half of the 28 chronic conditions). Conclusion: Although the proportion of individuals with the best possible health state is still very high, our findings support that the increase of levels provided by the EQ-5D-5L contributed to the validity and discriminatory power of this new version to measure health in general population, as in the national health surveys.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
    Shiroiwa, Takeru
    Fukuda, Takashi
    Ikeda, Shunya
    Igarashi, Ataru
    Noto, Shinichi
    Saito, Shinya
    Shimozuma, Kojiro
    QUALITY OF LIFE RESEARCH, 2016, 25 (03) : 707 - 719
  • [22] The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
    Bato, Alex
    Brodszky, Valentin
    Gergely, L. Hunor
    Gaspar, Krisztian
    Wikonkal, Norbert
    Kinyo, Agnes
    Szabo, Akos
    Beretzky, Zsuzsanna
    Szegedi, Andrea
    Remenyik, Eva
    Kiss, Norbert
    Sardy, Miklos
    Rencz, Fanni
    QUALITY OF LIFE RESEARCH, 2021, 30 (05) : 1477 - 1490
  • [23] Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease
    Rencz, Fanni
    Lakatos, Peter L.
    Gulacsi, Laszlo
    Brodszky, Valentin
    Kurti, Zsuzsanna
    Lovas, Szilvia
    Banai, Janos
    Herszenyi, Laszlo
    Cserni, Tamas
    Molnar, Tamas
    Pentek, Marta
    Palatka, Karoly
    QUALITY OF LIFE RESEARCH, 2019, 28 (01) : 141 - 152
  • [24] Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece
    Yfantopoulos, John N.
    Chantzaras, Athanasios E.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2017, 18 (04) : 519 - 531
  • [25] Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece
    John N. Yfantopoulos
    Athanasios E. Chantzaras
    The European Journal of Health Economics, 2017, 18 : 519 - 531
  • [27] EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery
    Gandhi, Mihir
    Ang, Marcus
    Teo, Kelvin
    Wong, Chee Wai
    Wei, Yvonne Chung-Hsi
    Tan, Rachel Lee-Yin
    Janssen, Mathieu F.
    Luo, Nan
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2019, 12 (04) : 383 - 392
  • [28] General population norms for the EQ-5D-3L in Norway: comparison of postal and web surveys
    Stavem, Knut
    Augestad, Liv A.
    Kristiansen, Ivar S.
    Rand, Kim
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2018, 16
  • [29] Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia
    Michalowsky, Bernhard
    Hoffmann, Wolfgang
    Mohr, Wiebke
    Raedke, Anika
    Xie, Feng
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2022, 20 (01)
  • [30] Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
    Moradi, Nasrin
    Poder, Thomas G.
    Safari, Hossein
    Mojahedian, Mohammad M.
    Ameri, Hosein
    FRONTIERS IN ONCOLOGY, 2022, 12